Skip to main content

Table 2 Score distribution of the SF-36 (2 summary measures) at hospital and after 12 months (per-protocol-analysis)

From: Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)

   

IG (n = 64)

CG (n = 119)

After 12 months

Between group comparison

SF-36 Scales

 

time

mean

(± SD)

mean

(± SD)

p-Value †

PCS

 

Hospital

41.8 (± 9.8)

41.2 (± 10.8)

 
  

After 12 months

41.5 (± 11.0)

38.1 (± 11.6)

0.090

 

p-Value ‡

Differences between baseline and after 12 months

0.313

0.023*

 

MCS

 

Hospital

49.5 (± 10.6)

49.6 (± 11.7)

 
  

After 12 months

48.1 (± 11.3)

45.0 (± 10.9)

0.077

 

p-Value ‡

Differences between baseline and after 12 months

0.831

0.001***

 
  1. SD = Standard deviation.
  2. † = The Mann-Whitney U test was used to compare the distribution of ranks between the groups.
  3. ‡ = The Wilcoxon Rank sum test was chosen to identify differences in each group at baseline and after 12 months.